[HTML][HTML] Fiber-type shifting in sarcopenia of old age: proteomic profiling of the contractile apparatus of skeletal muscles
P Dowling, S Gargan, D Swandulla… - International Journal of …, 2023 - mdpi.com
The progressive loss of skeletal muscle mass and concomitant reduction in contractile
strength plays a central role in frailty syndrome. Age-related neuronal impairments are …
strength plays a central role in frailty syndrome. Age-related neuronal impairments are …
[HTML][HTML] Adiponectin and its mimics on skeletal muscle: insulin sensitizers, fat burners, exercise mimickers, muscling pills… or everything together?
M Abou-Samra, CM Selvais, N Dubuisson… - International journal of …, 2020 - mdpi.com
Adiponectin (ApN) is a hormone abundantly secreted by adipocytes and it is known to be
tightly linked to the metabolic syndrome. It promotes insulin-sensitizing, fat-burning, and anti …
tightly linked to the metabolic syndrome. It promotes insulin-sensitizing, fat-burning, and anti …
[HTML][HTML] Integrated genomic, proteomic and cognitive assessment in Duchenne Muscular Dystrophy suggest astrocyte centric pathology
N Wijekoon, L Gonawala, P Ratnayake, P Dissanayaka… - Heliyon, 2023 - cell.com
Abstract Introduction Documented Duchenne Muscular Dystrophy (DMD) biomarkers are
confined to Caucasians and are poor indicators of cognitive difficulties and …
confined to Caucasians and are poor indicators of cognitive difficulties and …
[HTML][HTML] Modulating fast skeletal muscle contraction protects skeletal muscle in animal models of Duchenne muscular dystrophy
Duchenne muscular dystrophy (DMD) is a lethal muscle disease caused by absence of the
protein dystrophin, which acts as a structural link between the basal lamina and contractile …
protein dystrophin, which acts as a structural link between the basal lamina and contractile …
[HTML][HTML] “The Social Network” and muscular dystrophies: the lesson learnt about the niche environment as a target for therapeutic strategies
O Cappellari, P Mantuano, A De Luca - Cells, 2020 - mdpi.com
The muscle stem cells niche is essential in neuromuscular disorders. Muscle injury and
myofiber death are the main triggers of muscle regeneration via satellite cell activation …
myofiber death are the main triggers of muscle regeneration via satellite cell activation …
[HTML][HTML] Dimethyl fumarate modulates the dystrophic disease program following short-term treatment
New medicines are urgently required to treat the fatal neuromuscular disease Duchenne
muscular dystrophy (DMD). Dimethyl fumarate (DMF) is a potent immunomodulatory small …
muscular dystrophy (DMD). Dimethyl fumarate (DMF) is a potent immunomodulatory small …
[HTML][HTML] Mechanisms and clinical applications of glucocorticoid steroids in muscular dystrophy
M Quattrocelli, AS Zelikovich… - Journal of …, 2021 - content.iospress.com
Glucocorticoid steroids are widely used as immunomodulatory agents in acute and chronic
conditions. Glucocorticoid steroids such as prednisone and deflazacort are recommended …
conditions. Glucocorticoid steroids such as prednisone and deflazacort are recommended …
[HTML][HTML] The adiponectin receptor agonist, ALY688: a promising therapeutic for fibrosis in the dystrophic muscle
N Dubuisson, R Versele, MA Davis-López de Carrizosa… - Cells, 2023 - mdpi.com
Duchenne muscular dystrophy (DMD) is one of the most devastating myopathies, where
severe inflammation exacerbates disease progression. Previously, we demonstrated that …
severe inflammation exacerbates disease progression. Previously, we demonstrated that …
Histopathology of Duchenne muscular dystrophy in correlation with changes in proteomic biomarkers
M Zweyer, H Sabir, P Dowling, S Gargan, S Murphy… - 2022 - digitum.um.es
Duchenne muscular dystrophy is an inherited disorder of early childhood that affects
multiple systems in the body. Besides late-onset cardio-respiratory syndrome and various …
multiple systems in the body. Besides late-onset cardio-respiratory syndrome and various …
[HTML][HTML] Serum protein biomarkers for juvenile dermatomyositis: a pilot study
SM Tawalbeh, W Marin, GA Morgan, UJ Dang… - BMC rheumatology, 2020 - Springer
Background Blood accessible biomarkers to assess disease activity and their response to
therapies in Juvenile Dermatomyositis (JDM) are urgently needed. This pilot study aims to …
therapies in Juvenile Dermatomyositis (JDM) are urgently needed. This pilot study aims to …